Lobe Sciences Ltd. (CSE: LOBE)
Canada
· Delayed Price · Currency is CAD 0.0200
+0.0050 (33.33%)
Nov 22, 2024, 4:00 PM EST
Lobe Sciences Income Statement
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | May '24 May 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2018 |
| Revenue | 0.98 | 0.84 | - | - | - | 0.77 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 36.37% | Upgrade
|
| Cost of Revenue | 0.03 | 0.02 | - | - | - | - | Upgrade
|
| Gross Profit | 0.95 | 0.82 | - | - | - | 0.77 | Upgrade
|
| Selling, General & Admin | 2 | 2.58 | 3.07 | 4.08 | 1.96 | 2.03 | Upgrade
|
| Research & Development | 1.38 | 1.25 | 0.42 | 1.37 | - | - | Upgrade
|
| Operating Expenses | 3.77 | 4.18 | 4.12 | 6.38 | 3.62 | 3.68 | Upgrade
|
| Operating Income | -2.82 | -3.36 | -4.12 | -6.38 | -3.62 | -2.9 | Upgrade
|
| Interest Expense | -0.1 | -0.04 | - | - | - | - | Upgrade
|
| Interest & Investment Income | - | - | 2.2 | 1.57 | 0.02 | 0.03 | Upgrade
|
| Earnings From Equity Investments | -0 | -0.02 | -0.28 | -0.09 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.12 | -0.11 | -0.11 | -0.02 | -0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.04 | -9.73 | -8.45 | - | 3.94 | Upgrade
|
| EBT Excluding Unusual Items | -2.92 | -3.49 | -12.05 | -13.46 | -3.62 | 0.98 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.66 | -0.66 | -0.2 | -0.46 | - | - | Upgrade
|
| Asset Writedown | - | - | - | -7.35 | - | - | Upgrade
|
| Other Unusual Items | 0.82 | -0.35 | - | -2.58 | -0.06 | -1.74 | Upgrade
|
| Pretax Income | -2.76 | -4.5 | -12.25 | -23.84 | -3.68 | -0.75 | Upgrade
|
| Income Tax Expense | 0.21 | 0.21 | - | -1.02 | - | - | Upgrade
|
| Earnings From Continuing Operations | -2.97 | -4.71 | -12.25 | -22.82 | -3.68 | -0.75 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 13.16 | 0.25 | - | Upgrade
|
| Net Income | -2.97 | -4.71 | -12.25 | -9.66 | -3.44 | -0.75 | Upgrade
|
| Net Income to Common | -2.97 | -4.71 | -12.25 | -9.66 | -3.44 | -0.75 | Upgrade
|
| Shares Outstanding (Basic) | 119 | 104 | 38 | 32 | 13 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 119 | 104 | 38 | 33 | 13 | 8 | Upgrade
|
| Shares Change (YoY) | 60.10% | 175.61% | 15.91% | 160.26% | 57.51% | 86.75% | Upgrade
|
| EPS (Basic) | -0.02 | -0.05 | -0.32 | -0.30 | -0.27 | -0.09 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.05 | -0.32 | -0.32 | -0.28 | -0.09 | Upgrade
|
| Free Cash Flow | -1.07 | -1.72 | -2.73 | -5.04 | -1.22 | -2.04 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.07 | -0.15 | -0.10 | -0.26 | Upgrade
|
| Gross Margin | 97.36% | 97.14% | - | - | - | 100.00% | Upgrade
|
| Operating Margin | -289.04% | -399.67% | - | - | - | -375.10% | Upgrade
|
| Profit Margin | -303.68% | -560.04% | - | - | - | -97.50% | Upgrade
|
| Free Cash Flow Margin | -109.90% | -204.47% | - | - | - | -264.10% | Upgrade
|
| EBITDA | -2.71 | -3.32 | -4.11 | -6.16 | -3.41 | -2.53 | Upgrade
|
| D&A For EBITDA | 0.11 | 0.04 | 0.01 | 0.22 | 0.22 | 0.37 | Upgrade
|
| EBIT | -2.82 | -3.36 | -4.12 | -6.38 | -3.62 | -2.9 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.77 | Upgrade
|
| Advertising Expenses | - | 0.29 | 0.25 | 1.7 | 0.94 | 0.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.